![Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial]()
Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 TrialEngert, A.; Franklin, J.; Eich, H. T.; Brillant, C.; Sehlen, S.; Cartoni, C.; Herrmann, R.; Pfreundschuh, M.; Sieber, M.; Tesch, H.; Franke, A.; Koch, P.; de Wit, M.; Paulus, U.; Hasenclever, D.; Loeffler, M.; Muller, R.-P.; Muller-Hermelink, H. K.; Duhmke, E.; Diehl, V. · Journal of Clinical Oncology · 2007